Trial Profile
A Study to Investigate the Pharmacokinetic Drug-drug Interaction Following Oral Administration of BI 409306 and Donepezil in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Donepezil (Primary) ; Osoresnontrine (Primary)
- Indications Alzheimer's disease; Cognition disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017
- 15 Apr 2016 Status changed from active, no longer recruiting to completed.
- 24 Feb 2016 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov.